Alar SpO2 Sensor Study

计划入组 56 人 · 首次发布于 2024 年 5 月 3 日

Pressure Over Nasotracheal Intubation Related Nasal Alar Injury

首次发布于 2018 年 11 月 8 日

3D Evaluation of Nasolabial Changes Following Classic Versus Modified Alar Base Suture After Le Fort I Osteotomy

计划入组 40 人 · 首次发布于 2018 年 8 月 17 日

Romiplostim biosimilar (Intas Pharmaceuticals)

factor VIII nanoparticle (Zoetic Pharmaceuticals)

delta opioid agonists/mu opioid antagonists (Dina Pharmaceuticals)

Alar Pharmaceuticals Inc

Taiwan

MILESTONE PHARMACEUTICALS

India

XERIS PHARMACEUTICALS INC

United States

FDA Issues Untitled Letter to Alar Pharmaceuticals Over Promotion of Unapproved Ketamine Drug ALA-3000

Alar Pharmaceuticals Reports Breakthrough Phase 1 Results for Long-Acting Ketamine Injectable ALA-3000 in Treatment-Resistant Depression

HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)